High-Precision Radiotherapy Preserves Neurocognitive and Endocrine Function with Favorable Impact on Survival in Pediatric and Adolescent Low-Grade Gliomas
Neuro-Oncology Pediatrics · 19.11.2026
DOI: 10.1093/neuped/wuag064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Pediatrics, online erschienen am 19.11.2026. Verfasst von Suman Ghosh und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pediatric and adolescent low-grade gliomas (pLGGs) have excellent long-term survival, making treatment-related morbidity an important consideration. Radiotherapy (RT) remains an important modality for tumor control, particularly in progressive/refractory settings. This randomized trial subset analysis compares conventional RT (ConvRT) and Stereotactic Conformal RT (SCRT) to assess the clinical benefits of advanced techniques.
Methods
The pLGG subset comprised 102 patients (SCRT:56; ConvRT:46) and was analyzed with modified intention-to-treat approach to assess neurocognitive and endocrine function, overall survival (OS), progression-free survival (PFS) and local control (LC). Neurocognitive outcomes were measured from baseline to five years post-RT using age-appropriate Wechsler scales, with trends analyzed by Linear Mixed-Effects model.
Results
Median age was 12 years (IQR: 8–18). At a median follow-up of 174.5 months (IQR: 86.8–219.8), 15-year LC was 91.3% (95% CI, 85.7–97.2), and 15-year OS was 83.9% (95%CI, 76.4—92.1). Improved OS favoured SCRT (92.2% vs ConvRT 73.4%, adjusted HR,0.29; 95%CI, 0.09–0.96; P = 0.043), and pilocytic astrocytoma histology (p = 0.014). PFS numerically favored SCRT (p = 0.064), with no difference in LC (p = 0.25). SCRT showed significantly better full-scale-IQ trajectory (+1.82 points/year, p = 0.033) and improved performance quotient (+2.15,p=0.043). At 5 years, SCRT significantly reduced cumulative incidence of cognitive decline (≥10-point IQ drop), compared with ConvRT (30.6% vs 59.5%; SHR=0.43, p = 0.018), and neuroendocrine dysfunction (33.1% vs 56.2%; SHR=0.51, p = 0.027). ConvRT patients experienced higher cumulative incidence of vascular events (15.8% vs 2.9%, p = 0.09).
Conclusion
SCRT preserves neurocognitive and endocrine function with favourable long-term survival in pLGG, while maintaining high tumor control, supporting the use of high-precision RT techniques when indicated.
Zitieren
APA
Ghosh, S., Chatterjee, A., Dasgupta, A., Jain, N., Goswami, S., Krishna, U., Dutta, D., Jalali, R., Goda, J. S., & Gupta, T. (2026). High-Precision Radiotherapy Preserves Neurocognitive and Endocrine Function with Favorable Impact on Survival in Pediatric and Adolescent Low-Grade Gliomas. Neuro-Oncology Pediatrics. https://doi.org/10.1093/neuped/wuag064
Vancouver
Ghosh S, Chatterjee A, Dasgupta A, Jain N, Goswami S, Krishna U, et al. High-Precision Radiotherapy Preserves Neurocognitive and Endocrine Function with Favorable Impact on Survival in Pediatric and Adolescent Low-Grade Gliomas. Neuro-Oncology Pediatrics. 2026. doi:10.1093/neuped/wuag064
BibTeX
@article{Ghosh2026,
author = {Ghosh, Suman and Chatterjee, Abhishek and Dasgupta, Archya and Jain, Nidhi and Goswami, Savita and Krishna, Uday and Dutta, Debnarayan and Jalali, Rakesh and Goda, Jayant S and Gupta, Tejpal},
title = {High-Precision Radiotherapy Preserves Neurocognitive and Endocrine Function with Favorable Impact on Survival in Pediatric and Adolescent Low-Grade Gliomas},
journal = {Neuro-Oncology Pediatrics},
year = {2026},
doi = {10.1093/neuped/wuag064}
}
EUVIMED